DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trileptal (Oxcarbazepine) - Adverse Event Reports - Death

 



Index of reports > Cases resulting in death (12)

     Completed Suicide (3)Pneumonia (1)Pseudomonas Infection (1)Urinary Tract Infection (1)Somnolence (1)Convulsion (1)Blood Potassium Decreased (1)Arthralgia (1)Depressed Level of Consciousness (1)

Below is the selection of adverse event reports related to Trileptal (Oxcarbazepine) that includes cases resulting in death.

Adverse event in receiving Trileptal (Oxcarbazepine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30

Patient:

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Trileptal (Oxcarbazepine)



Adverse event in receiving Trileptal (Oxcarbazepine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30

Patient:

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Trileptal (Oxcarbazepine)



Adverse event in 1 year old female receiving Trileptal (Oxcarbazepine)

Reported by a consumer/non-health professional from Mexico on 2007-10-15

Patient: 1 year old female

Adverse reactions / side effects: Convulsion

Adverse event resulted in: death

Suspect drug(s):
Trileptal (Oxcarbazepine)



Adverse event in 89 year old female receiving Trileptal (Oxcarbazepine)

Reported by a consumer/non-health professional from Brazil on 2007-05-25

Patient: 89 year old female, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Urinary Tract Infection, Pseudomonas Infection, Arrhythmia, Surgery, Blood Potassium Decreased, Diarrhoea, Pulmonary Oedema, Hypertension, Respiratory Tract Infection

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Diovan
    Dosage: 80 mg, qd
    Administration route: Oral
    Indication: Hypertension

Slow-K
    Dosage: unk, tid
    Administration route: Oral
    Indication: Electrolyte Substitution Therapy

Trileptal
    Dosage: 150 mg/day
    Administration route: Oral
    Indication: Convulsion

Other drugs received by patient: Lamotrigine; Lasix; Motilium; Omeprazole; Ancoron; Anticoagulants



Adverse event in 25 year old male receiving Trileptal (Oxcarbazepine)

Reported by a pharmacist from United States on 2007-04-25

Patient: 25 year old male, weighing 90.7 kg (199.6 pounds)

Adverse reactions / side effects: Drug Interaction

Adverse event resulted in: death

Suspect drug(s):
Lamictal
    Indication: Bipolar Disorder

Trileptal
    Dosage: therapeutic doses
    Indication: Convulsion

Other drugs received by patient: Fentanyl; Oxycodone HCL



Adverse event in 25 year old male receiving Trileptal (Oxcarbazepine)

Reported by a physician from United States on 2007-04-13

Patient: 25 year old male, weighing 90.7 kg (199.6 pounds)

Adverse reactions / side effects: Arthralgia

Adverse event resulted in: death

Suspect drug(s):
Lamictal
    Indication: Bipolar Disorder

Trileptal
    Dosage: therapeutic doses
    Indication: Convulsion



Adverse event in male receiving Trileptal (Oxcarbazepine)

Reported by a pharmacist from United States on 2007-03-28

Patient: male

Adverse reactions / side effects: Overdose

Adverse event resulted in: death

Suspect drug(s):
Trileptal (Oxcarbazepine)



Adverse event in 80 year old female receiving Trileptal (Oxcarbazepine)

Reported by a consumer/non-health professional from Germany on 2007-03-23

Patient: 80 year old female

Adverse reactions / side effects: Dysphagia, Pneumonia, Depressed Level of Consciousness, Bronchitis, Somnolence, Loss of Consciousness

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Trileptal
    Dosage: 600 mg (10 ml) (0-0-10 ml)
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2006-11-23
    End date: 2006-11-23

Trileptal
    Dosage: 750 mg/d (2.5-0-10 ml)
    Administration route: Oral
    Start date: 2006-11-24
    End date: 2006-11-24

Trileptal
    Dosage: 600 mg/d (2.5-0-5 ml)
    Administration route: Oral
    Start date: 2006-11-25
    End date: 2006-11-25

Trileptal
    Dosage: 450 mg/d (2.5-0-5 ml)
    Administration route: Oral
    Start date: 2006-11-26
    End date: 2006-11-26

Trileptal
    Dosage: 430 mg/d (2.5-0-3 ml)
    Administration route: Oral
    Start date: 2006-11-27

Trileptal
    Dosage: 750 mg/d (0.5-0-2 df)
    Administration route: Oral
    Start date: 2006-01-01

Other drugs received by patient: Hydrocortisone; Astonin; Famotidine; Amantadine HCL; Levothyroxine Sodium; Baclofen; Baclofen



Adverse event in 14 year old female receiving Trileptal (Oxcarbazepine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-19

Patient: 14 year old female, weighing 83.9 kg (184.6 pounds)

Adverse reactions / side effects: Completed Suicide

Adverse event resulted in: death

Suspect drug(s):
Keppra
    Dosage: 250 mg, bid
    Administration route: Oral
    Indication: Convulsion
    Start date: 2006-11-28
    End date: 2006-12-05

Keppra
    Dosage: 500 mg, bid
    Administration route: Oral
    Start date: 2006-12-05
    End date: 2007-01-04

Trileptal
    Dosage: 600 mg, tid
    Indication: Convulsion
    Start date: 2005-11-11
    End date: 2007-01-04



Adverse event in 4 year old female receiving Trileptal (Oxcarbazepine)

Reported by a consumer/non-health professional from United States on 2007-02-23

Patient: 4 year old female, weighing 14.5 kg (31.9 pounds)

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Trileptal
    Dosage: 1 ml, bid
    Indication: Convulsion
    Start date: 2002-01-01

Trileptal
    Dosage: 3 ml, bid



Adverse event in 14 year old female receiving Trileptal (Oxcarbazepine)

Reported by a consumer/non-health professional from United States on 2007-02-06

Patient: 14 year old female, weighing 81.6 kg (179.6 pounds)

Adverse reactions / side effects: Completed Suicide

Adverse event resulted in: death

Suspect drug(s):
Keppra
    Dosage: 500mg bid po
    Administration route: Oral
    Indication: Convulsion
    Start date: 2006-11-28
    End date: 2007-01-10

Trileptal
    Dosage: 600mg tid po
    Administration route: Oral
    Indication: Convulsion
    Start date: 2005-11-15
    End date: 2007-01-10



Adverse event in 14 year old female receiving Trileptal (Oxcarbazepine)

Reported by a individual with unspecified qualification from United States on 2007-02-01

Patient: 14 year old female

Adverse reactions / side effects: Completed Suicide

Adverse event resulted in: death

Suspect drug(s):
Keppra
    Indication: Convulsion
    Start date: 2006-11-29

Trileptal
    Dosage: 600 mg, tid
    Indication: Convulsion
    Start date: 2006-08-01

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009